Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Topical treatments led to hair regrowth in a man with linear morphea.

Retinol may affect immune responses in people with frequent skin boils.

Thymic stromal lymphopoietin (TSLP) promotes hair growth by stimulating specific skin cells.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Interleukin-1 increases keratin K6 production in skin cells.

Alopecia areata patients have a higher risk of blood clots.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

The growth factor cocktail significantly increased hair growth in patients with androgenetic alopecia.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

IL-1 alpha stops hair follicle growth and hair production.

Atopic dermatitis shows a link between skin layers in inflammation, detectable with detailed gene analysis.

IL16 gene variations may affect the risk of alopecia areata in Koreans.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Type 2 inflammation helps wound healing by switching immune cells to repair mode.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.